Related Experiment Video
Updated: Jun 12, 2025

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Thrombolysis in dysfunctional valve and stroke
Dormar David Barrios-Martínez1,2,3, Yuri Valentina Pinzon4, Veronica Giraldo5
1Department of Critical Care, Hospital Universitario San Vicente Fundación, Medellin 050010, Antioquia, Colombia.
Insights
Prosthetic heart valve malfunction can cause stroke. Prompt diagnosis and treatment, including systemic thrombolysis, can restore valve function and improve patient outcomes in critical care settings.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Critical Care Medicine
Background:
- Valvular heart disease impacts over 100 million globally, with prevalence increasing with age.
- Mitral regurgitation and aortic stenosis are common, often requiring surgical valve replacement.
- Prosthetic heart valves can develop complications during peri-procedural or long-term follow-up.
Observation:
- A 71-year-old female with a history of mitral valve replacement presented with ischemic stroke.
- The patient's mitral prosthesis showed disc malfunction, suspected to be a microthrombotic lesion.
- Systemic thrombolysis was administered to address the suspected microthrombus.
Findings:
- The mitral prosthesis disc function normalized after systemic thrombolysis.
- The patient experienced reperfusion following the intervention.
- This suggests a potential link between prosthetic valve thrombosis and embolic events.
Implications:
- Highlights the importance of considering prosthetic valve dysfunction in stroke etiology.
- Emphasizes the critical role of a multidisciplinary team in managing complex cardiac cases.
- Demonstrates the efficacy of systemic thrombolysis in specific prosthetic valve complications.
Background:
Valvular heart disease affects more than 100 million people worldwide and is associated with significant morbidity and mortality. The prevalence of at least moderate valvular heart disease is 2.5% across all age groups, but its prevalence increases with age. Mitral regurgitation and aortic stenosis are the most frequent types of valvular heart disease in the community and hospital context, respectively. Surgical valve replacement (or mitral valve repair) is the standard of care for treating heart valve disease. However, the replacement of a prosthetic heart valve can lead to complications, either in the peri-procedural phase or in the long-term follow-up period.
Case Summary:
We present a case of a 71-year-old female patient with a history of mitral valve replacement and warfarin anti-coagulation therapy. She was admitted to the intensive care unit due to spontaneously reperfused ischemic stroke of probable cardioembolic etiology. A dysfunctional mitral prosthesis was identified due to malfunction of one of the fixed discs. Furthermore, a possible microthrombotic lesion was suspected. Therefore, systemic thrombolysis was performed with subsequent normalization of mitral disc opening and closing.
Conclusion:
This case underscores the critical importance of a multidisciplinary approach for timely decision-making in critically ill patients with prosthetic valve complications.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Clot Retraction and Fibrinolysis
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

